#GreatDebate #ACR23 @RheumNow Advanced Rx 1st line in PMR/GCA @philseo IL-6 research in RA (STREAM, MOBILITY): safety of toci, sarilumab - compares to ADA Ifn risk driven by GCs GUSTO: TCZ w/ only 3d GC pulse - 13/18 in remission 24, 52w PMR: "its not just a little bit of pred" https://t.co/sAlQ0pttcq